Semaglutide and Tirzepatide for slowing aging in adults with obesity
Treatments studied
Part of Hormones & metabolism clinical trials.
This trial tests if two newer weight-loss medications, semaglutide and tirzepatide, can help slow the aging process in adults with obesity. It compares the drugs to each other and to a placebo to see which might offer anti-aging benefits beyond weight loss.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have a body mass index (BMI) of 30 or higher, meaning you have obesity.
- You have not taken any weight-loss medications (like Wegovy, Ozempic, Mounjaro, or metformin for weight loss) in the past 3 months.
- You do not have diabetes that requires medication.
- You have never had pancreatitis, bariatric surgery, or a serious stomach problem.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a combination of two medications—a growth hormone-like drug and a semaglutide injection—to help adults with obesity lose weight. It aims to see if this combination is safe and effective for people who have not used these medications before.
This study tests whether two weight-loss medications, semaglutide and tirzepatide, combined with an exercise program can help people with obesity lose weight. It may help you if you are looking for a structured medical approach to weight loss.
This study tests whether the medication tirzepatide (a drug used for diabetes and weight loss) can slow the biological aging process in adults aged 55 to 70 who have excess weight. You would take the medication as a weekly injection for a set period, and researchers will monitor changes in your body's health markers.
This study looks at how anti-obesity medications like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) affect your muscles and movement. It may help researchers understand how to combine these drugs with exercise for better health.
This study tests whether adding an investigational drug (LUM-201) to a standard weight-loss medication (semaglutide) helps older adults with obesity lose more weight safely. It aims to see if the combination works better than semaglutide alone.
This trial compares two ways to manage weight: taking a GLP-1 medication (like tirzepatide or semaglutide) versus making lifestyle changes without medication. It will help researchers learn which approach works best for people with overweight or obesity.
Hear when a new Adults With Simple Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.